How can the BDNF gene be used as a gene of interest in genetic treatment of major depressive disorder?
Project by Polygence alum Emily
Currently awaiting publication in the International Youth Neuroscience Association (IYNA) journal.
They started it from zero. Are you ready to level up with us?
As depression rates increase among Americans, neuroscientists seek for more efficient targets for treating major depressive disorder (MDD) by focusing on biological mechanisms. Brain-derived neurotrophic factor (BDNF), a neurotrophic protein, has been shown to be associated with the development of neuropsychological disorders such as MDD. Thus, BDNF mechanisms are an ideal target in the search for effective treatments for depression, through antidepressants, physical exercise, and gene therapy.
PhD Doctor of Philosophy candidate
Biology, Psychology, Languages, Neuroscience, Medicine
Neuroscience, Cellular Biology, viruses, Pharmacology, Addiction, Science Communication, GABA, Dopamine, Neuropharmacology, Substance Abuse, Substance Use Disorders, Neural Circuitry, Mechanisms Underlying Disease, Cellular and molecular biology and developmental biology
Review of mentor
Nella helped me in so many ways. First of all, she emphasized throughout that this was an INDEPENDENT research project and that the direction of my paper was entirely in my hands. She did not do the research for me, although she often sent articles she thought would be helpful. Whenever I didn't understand a topic, she would clarify with me. She has gone above and beyond my expectations, and I am truly grateful I matched with her.